Mutational characteristics and clinical outcomes for lung adenocarcinoma with EGFR germline mutations.
Pan K, Owens J, Elamin Y, Lu C, Routbort M, Zhang J, Fossella F, Negrao MV, Altan M, Pozadzides J, Skoulidis F, Tsao A, Cascone T, Heymach JV, Ostrin E, Le X.
Pan K, et al. Among authors: zhang j.
J Thorac Oncol. 2024 Jun 10:S1556-0864(24)00614-2. doi: 10.1016/j.jtho.2024.06.004. Online ahead of print.
J Thorac Oncol. 2024.
PMID: 38866326